Total Payments
$6,904
2024 Payments
$1,791
Companies
39
Transactions
438
Medicare Patients
961
Medicare Billing
$57,034
Payment Breakdown by Category
Food & Beverage$6,904 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,904 | 438 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,047 | 72 | $0 (2024) |
| ABBVIE INC. | $962.14 | 74 | $0 (2024) |
| Novo Nordisk Inc | $848.68 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $654.69 | 32 | $0 (2024) |
| Amgen Inc. | $445.16 | 27 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $391.52 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $322.45 | 17 | $0 (2024) |
| Amarin Pharma Inc. | $264.04 | 18 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $263.76 | 15 | $0 (2024) |
| PFIZER INC. | $205.38 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,791 | 104 | AstraZeneca Pharmaceuticals LP ($320.71) |
| 2023 | $1,749 | 109 | Lilly USA, LLC ($323.95) |
| 2022 | $1,585 | 104 | Lilly USA, LLC ($256.69) |
| 2021 | $1,779 | 121 | Amarin Pharma Inc. ($226.42) |
All Payment Transactions
438 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes Care | ||||||
| 12/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Obesity | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $1.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $25.85 | General |
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $0.97 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.25 | General |
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Oncology | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 512 | 875 | $103,456 | $29,925 |
| 2022 | 10 | 395 | 662 | $85,466 | $24,125 |
| 2021 | 2 | 54 | 58 | $8,970 | $2,984 |
Total Patients
961
Total Services
1,595
Medicare Billing
$57,034
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 311 | $69,975 | $18,699 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 46 | $6,900 | $2,139 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $3,675 | $2,072 | 56.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 123 | 179 | $3,759 | $1,495 | 39.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,500 | $1,022 | 22.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 39 | 118 | $5,900 | $865.61 | 14.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 21 | 25 | $2,500 | $865.50 | 34.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $1,100 | $833.91 | 75.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 12 | 25 | $1,500 | $567.49 | 37.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 14 | 32 | $800.00 | $519.04 | 64.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 13 | $975.00 | $413.14 | 42.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $570.00 | $324.61 | 56.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 29 | 42 | $672.00 | $92.40 | 13.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 21 | $630.00 | $17.12 | 2.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 288 | $64,800 | $18,717 | 28.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $4,950 | $1,168 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 27 | $4,050 | $1,152 | 28.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 20 | 21 | $2,100 | $906.23 | 43.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 12 | 12 | $1,200 | $772.75 | 64.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 27 | 63 | $3,150 | $520.19 | 16.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 109 | 170 | $3,570 | $498.08 | 14.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $600.00 | $312.18 | 52.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 26 | $416.00 | $57.52 | 13.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 13 | 21 | $630.00 | $21.02 | 3.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 38 | $8,550 | $2,924 | 34.2% |
About Michael Colotta, FNP-C
Michael Colotta, FNP-C is a Family healthcare provider based in Henderson, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2012. The National Provider Identifier (NPI) number assigned to this provider is 1477824340.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Colotta, FNP-C has received a total of $6,904 in payments from pharmaceutical and medical device companies, with $1,791 received in 2024. These payments were reported across 438 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,904).
As a Medicare-enrolled provider, Colotta has provided services to 961 Medicare beneficiaries, totaling 1,595 services with total Medicare billing of $57,034. Data is available for 3 years (2021–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Henderson, TX
- Active Since 01/24/2012
- Last Updated 08/15/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1477824340
Products in Payments
- MOUNJARO (Drug) $464.80
- VRAYLAR (Drug) $456.08
- Kerendia (Drug) $391.52
- JARDIANCE (Drug) $380.76
- Ozempic (Drug) $353.92
- UBRELVY (Drug) $345.17
- FARXIGA (Drug) $279.94
- Vascepa (Drug) $264.04
- XARELTO (Drug) $263.76
- Rybelsus (Drug) $203.28
- BREZTRI (Drug) $201.36
- QUVIVIQ (Drug) $181.03
- Wegovy (Drug) $175.72
- TRULICITY (Drug) $163.89
- AIRSUPRA (Drug) $161.96
- Aimovig (Biological) $158.95
- Otezla (Drug) $147.98
- ELIQUIS (Drug) $131.43
- TRELEGY ELLIPTA (Drug) $129.28
- QULIPTA (Drug) $127.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Henderson
Kristy Solis
Family — Payments: $20,297
Family $20,297
Joseph Lau, Aprn, APRN
Family — Payments: $13,615
Family $13,615
Judith Yu, Aprn, APRN
Family — Payments: $11,118
Family $11,118
Daniel Sam Acierto
Family — Payments: $9,228
Family $9,228
Tad Titlow, Apn-C, APN-C
Family — Payments: $8,391
Family $8,391
Jackie Armijo, Fnp, FNP
Family — Payments: $8,206
Family $8,206